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Summary 
BACKGROUND: Perinatal mental disorders (PMDs) are the most 
common complication of pregnancy and the first postpartum year. 
Since PMD prevalence and use of mental-health services by perinatal 
women in Switzerland are unknown, we analysed existing health 
statistics. 
METHODS: We used statistics from a large health insurance compa-
ny, hospitals and freelance midwives. We assessed the annual rates 
of mental-healthcare use in perinatal women (n = 13 969). We ascer-
tained the annual rates of PMD treatment in obstetric inpatients 
(n = 89 699), and annual rates of PMD records by freelance midwives 
(n = 57 951). In 15 104 women who gave birth in 2012 or 2013, we 
assessed use of mental healthcare before and during pregnancy, and 
in the postpartum year. For the same sample, we determined pro-
portions of medication and consultation treatments. We used multi-
ple regression analysis to estimate the influence of PMD on overall 
healthcare costs of mandatory health insurance. 
RESULTS: The annual rate of mental-healthcare use by perinatal 
women was 16.7%. The annual rate of PMD treatment in obstetric 
inpatients was 1.1%. The annual rate of PMD records in the midwife-
ry care setting was 2.9%. Women with PMD use mental health ser-
vices mainly in non-obstetric outpatient settings. Medication was the 
most frequent treatment. Primary care providers and mental health 
specialists contributed almost equally to consultation treatments. 
PMD during pregnancy raised overall costs of healthcare in the 
postpartum year by 1214 Swiss francs. 
CONCLUSIONS: Health-system research and perinatal healthcare 
should take into consideration the high prevalence of PMD. Real PMD 
prevalence may be even higher than our data suggest and could be 
assessed with a survey using our model of PMD prevalence. 
Key words: mental disorder; prevalence; perinatal; pregnancy; post-
partum; health services; healthcare cost 
Introduction 
Perinatal mental disorders (PMDs) are mental and behavioural disor-
ders that appear during pregnancy or the first year after birth. PMDs 
affect up to 20% of women [1–5], but reported prevalence rates vary 
widely depending on method of assessment, the population and num-
ber of PMDs considered. PMD can have severe consequences, includ-
ing suicide risk [6], obstetric complications [7] and chronic mental 
illness [8]. Children of affected women can develop persistent emo-
tional, behavioural and cognitive problems [9]. In Great Britain, long-
term costs of inadequate treatment of PMD were estimated to be about 
10 000 British pounds per birth, and most of these costs relate to the 
child [10]. Despite high prevalence and adverse outcomes, PMD is 
often undiagnosed and untreated. In high-income countries, 36 to 50% 
of severe cases of mental disorder are untreated in the general popula-
tion [11] and the rate may be even higher in perinatal populations [5, 
12–14]. In the perinatal period women often hide symptoms because 
they fear the stigma connected to mental illness [15] or are afraid they 
may be considered inadequate mothers [16]. Mental-health services 
specifically for perinatal women are rare and often hard to access [17, 
18]. Such services must take into account obstetric conditions, consid-
er the health of the unborn or breastfed infant, bonding and attachment 
processes and parenting behaviour [9]. 
Great Britain developed comprehensive guidelines for detecting, 
assessing and treating PMD, in order to improve mental-health ser-
vices for perinatal women and ensure adequate treatment [19]. Aus-
tralia developed guidelines for detecting and treating perinatal depres-
sion in primary care [20]. The Swiss health agenda has not focused on 
perinatal mental health [21, 22]. PMD prevalence in Switzerland is 
unknown. Studies that used small inpatient samples report 12.5 to 
14% of “depression symptoms” in postpartum women during the first 
week, or 17 months after birth, and 37% of antenatal depression in 
migrants [23–25]. Freelance midwives recorded “maternal distress” in 
2.6% of a large sample within the first 10 days after birth [26]. Mental 
health services for perinatal women were assessed once, in 2007, 
when most cantons (65%) did not provide such specialised services in 
obstetric hospitals [18]. Outpatient general mental-health services are 
widely available in Switzerland and patients can access most of them 
directly. However, we do not know how many perinatal women use 
either specialised or general, inpatient or outpatient mental-health 
services. Nor are data available on the healthcare costs of PMD. This 
creates a substantial knowledge gap in perinatal mental health in 
Switzerland. 
Objectives 
To inform health system researchers and perinatal healthcare provid-
ers, we obtained data on PMD prevalence and use of mental health 
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services by perinatal women from existing Swiss databases. We had 
four specific objectives: 
1. To estimate annual prevalence rates of PMD based on (a) the 
mental health care use by perinatal women, (b) treatment of PMD 
in obstetric inpatients and (c) records of PMD in the midwifery 
homecare setting. 
2. To ascertain if prevalence and women’s trajectories of mental 
healthcare use changed in a period that started before pregnancy 
and included the perinatal periods. 
3. To quantify the relative contributions of medication and consulta-
tion to PMD treatment. 
4. To estimate the influence of PMD during pregnancy on overall 
health insurance costs in the first postpartum year. 
Materials and methods 
Databases and design 
We obtained data from the following sources (appendix 1): 
‒ The Helsana group (INS), one of the largest statutory health insur-
ance companies in Switzerland. In 2014, Helsana enrolled 1.2 mil-
lion Swiss residents with mandatory insurance, which is 15% of 
the general population (2014). INS contains data on health insur-
ance claims for all services covered by mandatory health insur-
ance. 
‒ Medical Statistics of Hospitals (MED) [27], the annual mandatory 
survey of all inpatients in Switzerland. MED accounts for about 
97% of births in Switzerland and contains ICD-10 diagnoses for 
treatments during the patient’s hospital stay [28]. 
‒ Statistics of Freelance Midwives (MID) [29]. MID is an annual 
survey of the services of freelance midwives and is mandatory for 
midwives affiliated with the Swiss Confederation of Midwives. 
MID contains PMD records by midwives and represents 71% of 
postpartum women in Switzerland (2014). 
We used the three different databases to look at mental health of 
perinatal women from different perspectives (objectives 1–4). For 
objective 1, we obtained a dataset from each database. We drew a 
second INS dataset for all other objectives. The datasets of all data-
bases are similar in that they represent or almost cover the population 
of perinatal women in Switzerland. However, they differ in healthcare 
setting, specific population and length of postpartum sub-periods, 
according to the availability of data. For reasons of data protection, it 
is not possible to identify individuals and aggregate them across 
datasets. We analysed the datasets independently. We detail inclusion 
and exclusion criteria for all datasets in  appendix 1. 
Settings 
INS data include all healthcare settings – inpatient and outpatient – 
that provide mental-health care and are covered by mandatory health 
insurance. MED data are drawn from inpatient obstetric settings in 
hospitals and midwife-lead birth centres. MID data are mainly drawn 
from outpatient obstetric settings, i.e. women’s homes and midwives’ 
practices, but also include midwife-led birth centres and hospital-
affiliated midwives [29]. 
Populations  and  periods 
For objective 1, we included from INS all perinatal women of the year 
2014. For the second INS dataset (objectives 2–4) we included women 
who gave birth in 2012 or 2013 (fig. S1, appendix 2). We included a 
3-month period before pregnancy to identify changes due to the 
perinatal state. We divided pregnancy and the postpartum year into 
trimesters to obtain trimester prevalence rates across all periods. From 
MED (objective 1), we analysed data from 2012, since there is always 
a 2-year lag in MED data. We included women who were inpatients 
during pregnancy, for birth and the following (average) 5 days [30], or 
were hospitalised in the postpartum period. Inpatient stays during 
pregnancy or after birth indicate complications that required treatment 
in an obstetric hospital, whereas women hospitalised for the birth are 
usually healthy. For the MID data (objective 1) we included women 
who received freelance midwifery care in 2014. Pregnant and early 
postpartum women with midwifery care are usually healthy. Beyond 
10 days after birth midwifery care required medial prescription, 
indicating the presence of complications that were treatable by the 
midwife. 
Endpoints 
The endpoints of the study indicated different aspects of PMD preva-
lence. “Use of mental-health services” is the endpoint derived from 
INS data. It reflects a broad spectrum of PMD from minor to the most 
severe cases because the data cover all mental-health services that are 
part of mandatory health insurance. The MED endpoint is “PMD 
treatment in obstetric hospitals”. It indicates PMD that was diagnosed 
and treated during the inpatient stay in an obstetric hospital. It reflects 
acute cases prominent in this setting. The endpoint of MID is “PMD 
record in freelance midwifery care”. It is based on the assessment of 
each midwife. 
 
Data analysis 
For objective 1, we calculated annual prevalence rates of the three 
endpoints and stratified MED and MID by perinatal sub-periods. For 
objective 2, we calculated 3-month prevalence rates of the use of 
mental-health services, including the trimester before pregnancy. We 
calculated the conditional percentages of women who used mental-
health services across the trimester before pregnancy, the entire preg-
nancy and postpartum year. For objective 3, we stratified use of 
mental-health services by medication and five types of consultation 
treatments, again for the trimester before pregnancy, entire pregnancy 
and first postpartum year. Women who received more than one type of 
treatment appear more than once in the calculations. To account for 
the different lengths of the periods, we present percentage proportions 
of all treatments within each period. For objective 4, we calculated 
costs of care in the first postpartum year using multiple linear regres-
sion. We used quantitative and categorical variables as predictors. To 
control for differences in health status, we considered pharmacy-based 
cost groups (PCGs) for the year before birth. PCGs are widely used to 
check for confounding by chronic diseases when information on 
clinical diagnosis is missing [31]. 
We determined 95% confidence intervals (CIs). We used R 3.1.2 for 
analysis of INS and MID, and SPSS 20.0 (IBM Corp, USA) for the 
MED analysis. 
Ethical statement 
In compliance with Swiss Federal Law on data protection (Human 
Research Act, Article 2), data were anonymised and irreversibly de-
identified to protect patient, physician, midwife and hospital privacy. 
Because data were retrospective, pre-existing, and de-identified, this 
study did not need approval from the ethics committee. 
Results 
Populations 
Table 1 shows the number of women included for each dataset and 
population (nall). Mean age (standard deviation) of women in the INS 
dataset was 32.1 (5.0) years, in MED 31.1 (5.1) years and in MID 32.0 
(4.9) years. In the MID sample, 58.3% of women were Swiss and 
41.0% had another nationality; 50.6% were primiparous and 49.4% 
were multiparous. 
 
  
Original article Swiss Med Wkly. 2017;147:w14417 
Swiss Medical Weekly · PDF of the online version · www.smw.ch   Page 3 of 9 
Published under the copyright license "Attribution - Non-Commercial - No Derivatives 4.0".  
No commercial reuse without permission. See http://emh.ch/en/services/permissions.html. 
Table 1: Annual prevalence rates of three indicators of perinatal mental disorders. 
Data Year Indicator of PMD Sampling period % PMD 95% CI nPMD nall 
INS 2014 Use of mental health care Pregnancy and postpartum year 16.7 16.1–17.4 2336 13 969 
MED 2012 Mental health treatments in 
obstetric hospital 
Pregnancy*, birth up to 5 days 
postpartum and postpartum year* 
1.1 1.1–1.2 1013 89 699 
Pregnancy* 1.5 1.3–1.6 387 26 530 
Birth up to 5 days postpartum 0.7 0.6–0.8 445 61 142 
Postpartum year* 5.7 5.4–7.0 189 3 301 
MID 2014 Records of freelance midwives Pregnancy, birth up to 10 days 
postpartum and postpartum yea† 
2.9 2.7–3.0 1660 57 951 
Pregnancy 2.9 2.6–3.2 330 11 326 
Birth up to 10 days postpartum 2.1 2.0–2.3 1152 54 057 
Beyond 10 days postpartum† 7.3 6.9–7.8 813 11 100 
CI = confidence interval; INS = Helsana health insurance data; MED = Medical Statistics of Hospitals; MID = Statistics of Freelance Midwives; nall = all perinatal women; nPMD = 
women with PMD; PMD = perinatal mental disorder; %PMD = annual prevalence rate 
Data in bold type cover almost identical populations, i.e. perinatal women in Switzerland. Data in italic type cover perinatal populations in the first days after birth. 
* Women with pathology that caused hospitalisation in an obstetric hospital 
† Medically prescribed midwifery care; for women with postpartum problems that can be treated by midwives 
 
Annual prevalence estimates (objective 1) 
The annual rates of the three indicators of PMD prevalence varied 
widely (table 1). They were highest for use of mental-health care and 
lowest for mental-health treatments in obstetric hospitals. Annual 
PMD records by freelance midwives are a small fraction of the rates 
of mental-health care use. Midwives referred 18.8% (n = 434) of the 
women they diagnosed with PMD to a mental-health specialist. 
Within the obstetric inpatient setting, PMD treatment rates were 
lowest for the large population of women who became inpatients for 
the birth. Similarly, PMD record rates in midwifery care are lowest 
shortly after birth up to 10 days postpartum. Women with obstetric 
complications in later postpartum periods had highest PMD treatment 
rates (MED) and highest PMD records by midwives (MID). 
The two most common PMD diagnoses that required mental-health 
treatment in obstetric inpatients were neurotic, stress-related and 
somatoform disorders (F4) and mood (affective) disorders (F3) (fig. 
S2, appendix 2). Among F4 diagnoses, anxiety disorders and stress 
disorders were treated most frequently (table S1, appendix 2). Among 
F43diagnoses, depressive episodes and recurrent depressive disorders 
made up almost 90%. Substance use disorders were also frequent 
(table S1).  
Use of mental-health services across periods (objective 2) 
Three-month prevalence rates 
When comparing 3-month periods, use of mental-health care was 
highest before pregnancy, lowest in the second trimester of pregnancy 
and increased thereafter until the end of the postpartum year, when it 
returned to the prepregnancy level (table 2). 
 
 
 
Table 2: Three-month prevalence rates of the use of mental health care.  
Period Trimester %PMD 95% CI nPMD 
Before preg-
nancy 
Last 9.5 9.0–9.9 1433 
Pregnancy 1 6.7 6.3–7.1 1015 
2 5.8 5.4–6.1 870 
3 6.8 6.4–7.3 1033 
Postpartum 
year 
1 6.6 6.2–7.0 997 
2 7.6 7.2–8.0 1146 
3 8.6 8.2–9.1 1303 
4 8.7 8.3–9.2 1318 
Source: women with Helsana health insurance who gave birth 2012 or 2013,  
n = 15 104 
Trajectories of use 
Figure 1 shows patterns of use during the 3-month period before 
pregnancy, during the entire pregnancy and during the postpartum 
year. Most of the women (74.1%) did not use mental-health services 
in any period (pattern 000). Most of the women who used mental-
health care, attended only in the postpartum year (001). Almost half of 
the women who used mental-health care before pregnancy stopped 
using it during pregnancy. A third of the women who had stopped 
using mental-health treatment during pregnancy resumed use of 
mental-health care in the postpartum year. A small group (3.6%) of 
women used mental-health care in all three periods (111). 
 
 
 
Figure 1: Trajectories of the use of mental healthcare for perinatal women in 
Switzerland, expressed as conditional percentages of women using mental health 
services (%) in consecutive periods. Red box or code 1: use of mental health 
services, blue box or code 0: no use of mental health services. The period patterns 
indicate three consecutive periods from left to right, e.g., the pattern 001 indicates 
use of mental health service postpartum, but not before pregnancy or during 
pregnancy. Helsana health insurance data. 
 
 
Types of mental-health services (objective 3) 
Medication was the most frequent treatment used in each perinatal 
period. In the last trimester before pregnancy, 6.8% (95% CI 6.4–7.2) 
of perinatal women used medication. To adjust for differences in 
period lengths, we present each treatment as a proportion of all treat-
ments within a period (fig. 2). During pregnancy, the proportion of 
medication use declined and the proportion of primary care consulta-
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tions increased. Consultations with mental-health specialists remained 
almost the same. During pregnancy and in the postpartum year, prima-
ry care providers contributed almost as much as specialists to mental-
health care. Delegated psychotherapy accounted for 7–9% of all 
mental-health treatments. Psychiatric hospitals contributed 0.2% of all 
treatments in the last trimester before pregnancy, 1.7% during preg-
nancy and 1.2% in the postpartum year. 
PMD and healthcare costs (objective 4) 
Age of the women, pharmaceutical cost group markers, managed care, 
high franchise, complicated vaginal birth or complicated caesarean 
section, and mental illness during pregnancy were variables that 
influenced costs within mandatory health insurance in the postpartum 
year (table 3). Mental illness during pregnancy raised costs in the 
postpartum year by CHF 1214, which was more than the other factors. 
 
 
 
Figure 2: Proportions of medication and five types of consultation by period. For women who gave birth in Switzerland 2012 or 2013 (n = 15 104), Helsana health insurance data.  
*Services summarised here also include a minor fraction provided by gynaecologists and other care providers. 
 
 
Table 3: Costs of health care in the postpartum year as influenced by perinatal mental disorder during pregnancy and other predictors (Multiple Linear Regression). 
Predictor variable 
 
Coefficient 95% CI p-value 
Intercept = 233.5 
Age of women 28.0 12.7–43.3 <0.001 
Pharmaceutical cost group* 1182.0 1119.8–12 442 <0.001 
Managed care −285.8 −442.5– −129.1 <0.001. 
Private insurance 45.5 −179.8–270.8 n.s. 
Latin canton 32.3 −140.1–204.7 n.s. 
High franchise (CHF >500) −353.2 −515.0– −191.4 <0.001 
Caesarean section 35.5 −157.9–228.9 n.s. 
Vaginal birth with complications 353.2 150.3–556.0 <0.001 
Caesarean section with complications 477.2 244.0–710.3 <0.001 
PMD during pregnancy* 1214.4 974.8–1454.0 <0.001 
CI = confidence interval; n.s. = not statistically significant; PMSD = perinatal mental disorder 
Source: women who gave birth in Switzerland 2012 or 2013 (n = 15 104); Helsana health insurance data 
Multiple R2: 0.1325, Adjusted R2: 0.1319, df: 15 093 
* Indicates morbidity 
 
Discussion 
Main findings 
We found that 16.7% of perinatal women per year, every sixth wom-
en, used mental-health services in Switzerland. In obstetric hospitals, 
1.1% of perinatal women were treated for PMD during their inpatient 
stay. For a small minority of women (2.9%), PMD was recorded by 
midwives in the home care setting. Medication was the most common 
treatment for PMD. Women with PMD consulted mainly with mental-
health specialists, but primary care providers contributed almost as 
much as specialists to mental-health care in the perinatal period in the 
postpartum year, Mental illness in pregnancy was associated with an 
increase of CHF 1214 in basic health insurance costs. 
Strengths and limitations 
We know of no other study that estimates PMD prevalence in Switzer-
land. The study was strengthened by the use of data from large popu-
lations. The INS population represents about 15% of perinatal women 
in Switzerland, MED covers 98% of births and MID covers 71% of all 
early postpartum women in Switzerland, so the chance of selection 
bias is small, and MID and MED almost comprise the Swiss perinatal 
population. The analyses of the three different databases create a 
comprehensive picture of PMD prevalence: this includes a broad 
range of PMD and healthcare settings, brings together women from all 
perinatal periods, with and without obstetric complications. For the 
entire perinatal period, populations of the different datasets are very 
comparable. 
The study is limited by the fact that the datasets are not completely 
unique: Some are from the same years and women can appear in more 
than one dataset when they switch services. However, we analysed the 
data independently. MED and MID almost comprise the entire perina-
tal population, but are from different years. 
Criteria for PMD were limited because the available databases are not 
designed to provide PMD diagnoses. MED contains only the most 
prominent cases of PMD that appear and are treated during inpatient 
stays in obstetric hospitals. Diagnoses in MID rely on individual 
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assessments of each midwife [29]. We could determine use of mental-
health services for mandatory insurance, but not for supplementary 
insurance and self-paid services, and so we may have underestimated 
mental-health services use. 
Estimates of PMD prevalence 
We did not expect to find that use of mental-health services in Swit-
zerland was so common among perinatal women, since reports of 
undertreatment of PMD are abundant [5, 10, 12–14, 17]. Our defini-
tion of use of mental-health services was broad and included a wide 
range of severities of PMD. Nevertheless, PMD may be underdiag-
nosed in Switzerland because systematic screening is key to detecting 
PMD [13, 19], but is not part of routine obstetric care in Switzerland 
[18, 29]. Perinatal women are cautious about reporting symptoms of 
mental illness to health professionals [32], and obstetricians and 
midwives are usually not well-trained to deal with mental illness [13, 
16]. A US study that assessed PMD retrospectively using diagnostic 
criteria, found annual prevalence rates of 25% and 28% in past-year-
pregnant and postpartum women [5]. Given the fact that our INS data 
cover only women who used mental-health services, we suspect that 
INS data underestimate PMD. 
Only 1.1% per year of obstetric inpatients received mental-health 
treatment during their hospital stay. These women have severe forms 
of PMD, since their symptoms were considered clinically relevant in 
settings that did not specialise in mental disorders. In this population, 
women who came to the hospital for birth and stay there on average 5 
days prevail. During this short period, postpartum mental-health 
problems may not manifest, or are considered by the women as transi-
ent and part of normal adjustment [17]. 
Apart from birth, perinatal women become inpatients in obstetric 
hospitals when they experience complications of pregnancy and the 
postpartum period. Such conditions increase the risk of PMD [1, 33, 
34]. Accordingly, these women were treated for PMD more frequently 
than inpatients for the birth only. In the postpartum period, stress or 
sleep deprivation are common [35]. Women with physical complica-
tions might be more affected by these stressors than healthy women. 
For further research, we suggest a pyramid model that considers 
different severities of PMD. The basis is women who have minor 
mental problems, do not seek professional help and try to cope on 
their own [32]. Other women experience impaired well-being and are 
ready to inform health professionals about their symptoms. These 
women use outpatient mental-health care and prevail in our INS data 
(fig. 2). Women with or without obstetric problems need mental-
health care as inpatients in obstetric hospitals and a minority, the most 
severe cases, are treated in psychiatric hospitals. Because of the 
stigma related to PMD [15], women of all groups, including those 
with severe disorders, may avoid mental-health care and remain 
undiagnosed and untreated. True prevalence must include all these 
groups and can be assessed with a survey. 
Use of mental-health services 
By periods and women’s trajectories 
The use of mental-health care was highest in the trimester before 
pregnancy (9.5%) – almost twice the 5% mental-health treatment rate 
of the general population in Switzerland in 2012 [36]. Without know-
ing about the impending pregnancy, women might fear stigma less 
and speak more about mental-health problems. The 30% drop in the 3-
month prevalence rate of mental-health care use with the onset of 
pregnancy could reflect women who stop medication when they 
become pregnant [37]. This is supported by the observation that the 
rates decline further in the second trimester of pregnancy when almost 
all women are aware of their pregnancy. Our 3-month prevalence rates 
for healthcare use do not indicate a peak of PMD in the postpartum 
year, in line with a meta-analysis of depression prevalence [3], but 
indicate a drop with the onset of pregnancy. 
The trajectories for perinatal women reflect diverse individual histo-
ries, invisible in 3-month prevalence rates. Mental health can be 
unaltered by pregnancy or the postpartum state, can improve for 6% 
and can worsen for 16.4% of women. This may create different de-
mands in mental-health care. Women who have mental-health prob-
lems already in the trimester before pregnancy should be targeted 
early to help them to adjust their treatment to pregnancy, particularly 
in the case of psychiatric medication [19, 38]. The large group of 
women with PMD who did not use mental-health services before 
pregnancy might experience mental-health problems for the first time. 
Healthcare services should focus on this population, because it is not 
familiar with symptoms and treatment of mental disorders. 
Type of care 
The most frequent treatment was medication, although women seem 
to prefer nonpharmacological depression treatment [39]. There are 
medicines appropriate for treating PMD, but they still pose health 
risks to unborn or breastfed children [38]. Mental-health care provid-
ers should consider the woman’s need to decide about her treatment. 
Balanced advice should include the higher threshold for pharmacolog-
ical treatment in the perinatal period, and the adverse effects and 
benefits of a psychological intervention [19]. Perinatal healthcare 
providers should be aware of the high use of medication. 
Our results show that mental-health services for women with PMD are 
mainly provided in nonobstetric outpatient settings. We found that 
9.8% of perinatal women receive mental-health consultations from a 
general practitioner. There is evidence that general practitioners 
efficaciously treated postnatal depression, particularly when it was 
combined with cognitive-behavioural counselling by a mental-health 
specialist or a trained midwife or nurse [40]. The contribution of 
freelance obstetricians to perinatal mental-health consultations was 
low. This is in line with the situation in the US, where obstetricians 
diagnosed, treated and referred only a minority of women with perina-
tal depression [41]. 
PMD and healthcare costs 
The finding that mental illness raised overall healthcare costs for 
perinatal women was also the case for general populations [42, 43]. 
The increase due to PMD was CHF 1214 and is 15% of the average 
annual healthcare costs (2014) of Swiss inhabitants [44]. Depression 
severity is a strong predictor for using mental-health services [45]. 
Severe mental illnesses such as psychoses create particularly high 
costs [42], mainly as a result of chronic medical comorbidity and poor 
management of the mental illness. Overall healthcare costs for persons 
with chronic psychoses were CHF 4726 in 2009 [42]. Such cases – 
though rare in our study– may have increased the average costs. 
Conclusion 
Health-system researchers and perinatal healthcare providers should 
focus on the high prevalence of PMD, and seek to ensure that preg-
nant and postpartum women are adequately treated in all perinatal 
periods and in all settings. The high rate of mental-health service use 
represents women so much impaired by PMD that they actively seek 
professional help, or are referred to it; this rate, though high, suggests 
real PMD prevalence in Switzerland is even higher. 
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Appendix 1: Inclusion and exclusion criteria 
Helsana health insurance data (INS) 
To identify women who gave birth 2012 or 2013 we used the date of 
entry of the diagnosis group code (DRG) for birth as a proxy for the 
date of birth (fig. S1). We used all 12 DRG codes for vaginal birth or 
caesarean section (table S2). We excluded women who had given 
birth more than once during the time frames. Twins are treated as a 
single birth. To avoid observation gaps, we excluded 17 813 women 
who did not have continuous Helsana insurance. We proceeded simi-
larly to identify women who were perinatal in 2014. Perinatal women 
were determined to have used mental health services if Helsana com-
pensated the provider at least once for at least one of the following 
services: 
1. Psychiatric medication; 
2. Consultation with psychiatrist or psychological professional; 
3. Psychotherapeutic or psychosocial consultation; 
4. Delegated psychotherapy; 
5. Any inpatient stay with ICD-10 F-diagnosis as main or side diag-
nosis, F17 (tobacco use) as sole F-diagnosis was excluded; 
6. Inpatient stay in psychiatric hospital. 
Services under criteria 3 are mainly provided by general practitioners, 
i.e., to 77% of perinatal women (n = 2 992). Mental health specialists 
(to 5.4% of women), gynaecologists (6.5% of women), general hospi-
tals (10.8% of women) and psychiatric hospitals (0.1% of women) 
contributed also. Two perinatal psychiatric experts of the Psychiatric 
University Hospital Bern advised us on definitions of perinatal psy-
chiatric medication, and we used the World Health Organization 
classification for drugs [39] (table S2). 
Medical Statistics of Hospitals (MED) 
In MED, the most significant health problem associated with the 
hospital stay is coded as the main diagnosis [37]. Further diagnoses 
are recorded as side diagnoses. For 2012, we selected all records of 
inpatients aged 15–50 years, whose main diagnosis related to preg-
nancy (O10–O48), childbirth (O60–O82) or the puerperium (O85–
O92, O94, O98, O99) (ICD-10, n = 92 967). Of the women we select-
ed, 3% were obstetric inpatients more than once in 2012. Using the 
anonymous linking code we aggregated records to individual perinatal 
women. Within all perinatal women, women with PMD were identi-
fied from a mental side diagnosis (ICD-10 F-diagnoses). F10–99 were 
considered, but women with F17 (tobacco use) as sole F-diagnosis 
were excluded (n = 383). 
Statistics of the Freelance Midwives (MID) 
In 2014, freelance midwives recorded care of 62 917 cases. Approxi-
mately 7–11% of women were recorded by more than one midwife. 
We refer to each record as a single woman. Though reporting the 
mental status during pregnancy or early postpartum period is volun-
tary, in 2014 it was reported in 92% of all cases. We included all cases 
for whom the mental health status was reported (n = 57 951). Mid-
wives diagnose PMD on their own assessment. They can record in the 
survey “mental health problems” or “depression” or “postpartum 
depression”. We refer to all these diagnoses as PMD. We assigned 
women to perinatal sub-periods depending on when midwives cared 
for them. 
 
Appendix 2: Supplementary figures and tables 
 
 
 
Figure S1: Definition of periods in Helsana 
health insurance data (INS). Lengths of 
periods were calculated on a 12 months 
per year and 30 days per month basis 
(360/30). X denotes the hospital inpatient 
stay after birth, on average 5 days 2012–
2014 [30] 
 
  
 
Figure S2: Percentages of diagnostic groups 
of mental disorders (% of all recoded F-
diagnoses; n = 1174); ICD-10 F-diagnoses at 
the 2-character level* recorded in inpatient 
obstetric care. Medical Statistics of Hospi-
tals, 2012. 
* WHO. The ICD-10 classification of mental 
and behavioural disorders: Clinical descrip-
tions and diagnostic guidelines. 2010. 
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Table S1: Proportion of diagnostic groups of all perinatal mental disorders (% of all recorded F-diagnoses, n = 1174).  
ICD-10 code*
 Mental and behavioural disorder n % 
F40–F48 Neurotic, stress-related and somatoform disorders 360 100.0 
F41 Other anxiety disorders 172 47.8 
F43 Reaction to severe stress, and adjustment disorders 154 42.8 
F40 Phobic anxiety disorders 13 3.6 
F45 Somatoform disorders 13 3.6 
F42 Obsessive-compulsive disorder 4 1.1 
F44 Dissociative [conversion] disorders 2 0.6 
F48 Other neurotic disorders 2 0.6 
F30–F39 Mood [affective] disorders 352 100.0 
F32 Depressive episode 260 73.9 
F33 Recurrent depressive disorder 55 15.6 
F31 Bipolar affective disorder 26 7.4 
F34 Persistent mood [affective] disorders 3 0.9 
F30 Manic episode 1 0.3 
F38 Other mood [affective] disorders 1 0.3 
F10–F19 Mental and behavioural disorders due to psychoactive substance use 264 100.0 
F17 ...due to use of tobacco 74 28.0 
F11 ...due to use of opioids 61 23.1 
F12 ...due to use of cannabinoids 58 22.0 
F19 ...due to multiple drug use and use of other psychoactive substances 24 9.1 
F14 ...due to use of cocaine 20 7.6 
F10 ...due to use of alcohol 13 4.9 
F13 ...due to use of sedatives or hypnotics 9 3.4 
F15 ...due to use of other stimulants, including caffeine 4 1.5 
F16 ...due to use of hallucinogens 1 0.4 
Source: Medical Statistics of Hospitals, 2012, Switzerland. 
* ICD-10 F-diagnostic groups at the three-character level. From: WHO. The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guide-
lines. 2010. 
 
Table S2: Diagnosis Related Group codes used to identify women in Helsana health 
insurance data (INS), who gave birth in Switzerland 2012–2013, or were perinatal in 
2014.  
DRG*
 
Diagnosis 
O01A Caesarean section with several complicating diagnoses, duration of 
pregnancy up to 25th complete week or with intrauterine therapy 
O01B Caesarean section with several complicating diagnoses, duration of 
pregnancy 26 up to 33 complete weeks, without intrauterine therapy 
or with complicating diagnosis, up to week 25 or thromboembolism 
during pregnancy with OR-procedure 
O01C Caesarean section with several complicating diagnoses, duration of 
pregnancy > 33 complete weeks, without intrauterine therapy or with 
complicating diagnoses, 26 up to 33 week of pregnancy or with 
complex diagnose, or up to week 33 of pregnancy or with complicat-
ing diagnosis with most severe CC 
O01D Caesarean section with several complicating diagnoses, pregnancy 
duration > 33 complete weeks, without intrauterine therapy or with 
complicating diagnosis, 26 up to 33 week of pregnancy or with 
complicating diagnosis or up to 33 week of pregnancy or with compli-
cating diagnosis, without most severe CC 
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O01E Caesarean section with complicating diagnosis, pregnancy duration 
more than 33 complete weeks, without complex diagnosis 
O01F Caesarean section without complicating diagnosis, pregnancy dura-
tion more than 33 complete weeks, without complex diagnosis 
O02A Vaginal birth with complicating OR-procedure, pregnancy duration up 
to 33 complete weeks with intrauterine therapy 
O02B Vaginal birth with complicating OR-procedure, pregnancy duration 
more than 33 complete weeks, without intrauterine therapy 
O60A Vaginal birth with several complicating diagnoses, at least one severe, 
pregnancy duration up to 33 complete weeks or with complicating 
procedure 
O60B Vaginal birth with several complicating diagnoses, at least one severe, 
pregnancy duration more than 33 complete weeks, without compli-
cating procedure or thromboembolism during pregnancy without OR-
procedure 
O60C Vaginal birth with complicating diagnosis, severe or moderately 
severe 
O60D Vaginal birth without complicating diagnosis 
DRG = diagnosis related groups; CC = complications or comorbidities; OR = surgery 
(operating room). 
* obtained from http://swissdrg.org (translated) 
 
Table S3: Definition of psychiatric medication in Helsana health insurance data (INS); at 
least one medication was required to classify a woman as receiving psychiatric medica-
tion. 
One supply with a drug with one of the following Anatomical Therapeutic Chemical 
(ATC) codes*: 
M03BX*, N01AH01, N01AX03, N01AX10, N02AA01, N02AA04, N02AA05, N02AA10, 
N02AB03, N02AC52, N02AE01, N02AX*, N03AB02, N03AF01, N03AG01, N03AX11, 
N03AX14, N03AX16, N05A*, N05BA*, N05CD*, N05CF*, N05CX11, N06AA*, N06AB*, 
N06AF*, N06AG*, N06AX*, N06C*, N07B* 
* WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC 
classification and DDD assignment. 2014: Oslo. 
 
